Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities

No abstract is available for this paper.

• Publication year

  2014

• Venue

  British Journal of Pharmacology

• Publication date

  2014-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bph.12416PMID 24684389PMCID PMC3976618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification through high‐throughput screening of 4'‐methoxyflavone and 3',4'‐dimethoxyflavone as novel neuroprotective inhibitors of parthanatos

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: Ion Channels

  2013cited by this paper
• The Concise Guide to Pharmacology 2013/14: Overview

  2013cited by this paper
• Reprogramming cellular events by poly(ADP-ribose)-binding proteins

  2012cited by this paper
• PARPs and the DNA damage response.

  2012cited by this paper
• Ferroptosis: an iron-dependent form of nonapoptotic cell death.

  2012cited by this paper
• Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

  2011influential reference
• Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death

  2011cited by this paper
• Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase.

  2011influential reference
• Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage

  2011cited by this paper
• Apoptosis-Inducing Factor: Structure, Function, and Redox Regulation

  2011cited by this paper
• Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1–Dependent Cell Death (Parthanatos)

  2011influential reference
• Endonuclease G does not play an obligatory role in poly(ADP-ribose) polymerase-dependent cell death after transient focal cerebral ischemia.

  2010cited by this paper
• Poly(ADP-Ribose) Metabolism in Brain and Its Role in Ischemia Pathology

  2010influential reference
• PARP inhibition: PARP1 and beyond

  2010cited by this paper
• Protective effect of nicotinamide against poly(ADP-ribose) polymerase-1-mediated astrocyte death depends on its transporter-mediated uptake.

  2010cited by this paper
• Recovery

  2010cited by this paper
• Multifaceted deaths orchestrated by mitochondria in neurones.

  2010cited by this paper
• Astrocytic poly(ADP‐ribose) polymerase‐1 activation leads to bioenergetic depletion and inhibition of glutamate uptake capacity

  2009cited by this paper
• Poly (ADP-ribose) polymerase-1-inhibiting flavonoids attenuate cytokine release in blood from male patients with chronic obstructive pulmonary disease or type 2 diabetes.

  2009cited by this paper
• PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

  2009influential reference
• Genome-wide silencing in Drosophila captures conserved apoptotic effectors

  2009influential reference
• Calpain activation is not required for AIF translocation in PARP‐1‐dependent cell death (parthanatos)

  2009influential reference
• Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release

  2009influential reference
• Parthanatos, a messenger of death.

  2009influential reference
• Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos.

  2009influential reference
• Critical role of poly(ADP‐ribose) polymerase‐1 in modulating the mode of cell death caused by continuous oxidative stress

  2009cited by this paper
• Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke.

  2009cited by this paper
• Selective Down-Regulation of Nuclear Poly(ADP-Ribose) Glycohydrolase

  2009cited by this paper
• Advances in neuronal cell death 2007.

  2008cited by this paper
• Oxidative stress in neurodegeneration and available means of protection.

  2008cited by this paper
• Mitochondrial and Nuclear Cross Talk in Cell Death

  2008influential reference
• Bid-induced release of AIF from mitochondria causes immediate neuronal cell death

  2008cited by this paper
• Imidazoquinolinone, Imidazopyridine, and Isoquinolindione Derivatives as Novel and Potent Inhibitors of the Poly(ADP-ribose) Polymerase (PARP): A Comparison with Standard PARP Inhibitors

  2008cited by this paper
• Poly(ADP-ribose) polymerase: a new therapeutic target?

  2008cited by this paper
• PARP-1 Inhibition Prevents Oxidative and Nitrosative Stress–Induced Endothelial Cell Death via Transactivation of the VEGF Receptor 2

  2008cited by this paper
• Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease.

  2008influential reference
• Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit?

  2008cited by this paper
• Poly(ADP-ribose)polymerase-1 (PARP-1) in carcinogenesis: potential role of PARP inhibitors in cancer treatment

  2008influential reference
• Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes

  2008influential reference
• On the Way to Selective PARP‐2 Inhibitors. Design, Synthesis, and Preliminary Evaluation of a Series of Isoquinolinone Derivatives

  2008cited by this paper
• A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor

  2008cited by this paper
• Critical Role of Calpain I in Mitochondrial Release of Apoptosis-Inducing Factor in Ischemic Neuronal Injury

  2007cited by this paper
• The selective poly(ADP)ribose-polymerase 1 inhibitor INO1001 reduces spinal cord injury during porcine aortic cross-clamping-induced ischemia/reperfusion injury

  2007cited by this paper
• Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.

  2007cited by this paper
• Poly(ADP-ribose) polymerase inhibition by cilostazol is implicated in the neuroprotective effect against focal cerebral ischemic infarct in rat.

  2007cited by this paper
• PARP-1-induced cell death through inhibition of the MEK/ERK pathway in MNNG-treated HeLa cells

  2007cited by this paper
• Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia

  2007cited by this paper
• Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.

  2007cited by this paper
• Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications.

  2007cited by this paper
• Therapeutic potential of AIF-mediated caspase-independent programmed cell death.

  2007influential reference
• Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia

  2007cited by this paper
• Two small enzyme isoforms mediate mammalian mitochondrial poly(ADP-ribose) glycohydrolase (PARG) activity.

  2007cited by this paper
• Flavone as PARP-1 inhibitor: its effect on lipopolysaccharide induced gene-expression.

  2007cited by this paper
• Pharmacological inhibition of PARP-1 reduces alpha-synuclein- and MPP+-induced cytotoxicity in Parkinson's disease in vitro models.

  2007cited by this paper
• Use of a Poly(ADP-Ribose) Polymerase Inhibitor to Suppress Inflammation and Neuronal Death After Cerebral Ischemia-Reperfusion

  2007cited by this paper
• N-Methyl-N′-Nitro-N-Nitrosoguanidine Activates Multiple Cell Death Mechanisms in Human Fibroblasts

  2007cited by this paper
• Identification and Characterization of AIFsh2, a Mitochondrial Apoptosis-inducing Factor (AIF) Isoform with NADH Oxidase Activity*

  2006cited by this paper
• Genotype‐dependent priming to self‐ and xeno‐cannibalism in heterozygous and homozygous lymphoblasts from patients with Huntington's disease

  2006cited by this paper
• Poly(ADP-ribose) (PAR) polymer is a death signal

  2006influential reference
• EndoG is dispensable in embryogenesis and apoptosis

  2006cited by this paper
• Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death

  2006influential reference
• AIFsh, a Novel Apoptosis-inducing Factor (AIF) Pro-apoptotic Isoform with Potential Pathological Relevance in Human Cancer*

  2006cited by this paper
• Poly(ADP-ribose) Accumulation and Enhancement of Postischemic Brain Damage in 110-kDa Poly(ADP-ribose) Glycohydrolase Null Mice

  2006cited by this paper
• Cell death in the nervous system

  2006cited by this paper
• Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling.

  2006cited by this paper
• Dynamic relocation of poly(ADP-ribose) glycohydrolase isoforms during radiation-induced DNA damage.

  2006cited by this paper
• Poly(ADP-ribose) glycohydrolase silencing protects against H2O2-induced cell death.

  2006cited by this paper
• MNNG-induced Cell Death Is Controlled by Interactions between PARP-1, Poly(ADP-ribose) Glycohydrolase, and XRCC1*

  2006cited by this paper
• Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space

  2005cited by this paper
• Clinical perspectives of PARP inhibitors.

  2005cited by this paper
• BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of poly (ADP-ribose) polymerase: An issue of potency

  2005cited by this paper
• Tankyrase-1 overexpression reduces genotoxin-induced cell death by inhibiting PARP1

  2005cited by this paper
• Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.

  2005cited by this paper
• The monofunctional alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine triggers apoptosis through p53-dependent and -independent pathways.

  2005influential reference
• Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP‐ribose) polymerase‐1/2 inhibitors

  2005cited by this paper
• Pharmacological manipulation of cell death: clinical applications in sight?

  2005cited by this paper
• Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications.

  2005influential reference
• Apoptosis-Inducing Factor Is a Key Factor in Neuronal Cell Death Propagated by BAX-Dependent and BAX-Independent Mechanisms

  2005influential reference
• Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

  2005cited by this paper
• Expression pattern of apoptosis-related markers in Huntington’s disease

  2005cited by this paper
• Discovery of potent poly(ADP-ribose) polymerase-1 inhibitors from the modification of indeno[1,2-c]isoquinolinone.

  2005cited by this paper
• Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

  2005cited by this paper
• Classification of cell death: recommendations of the Nomenclature Committee on Cell Death

  2005cited by this paper
• Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.

  2005cited by this paper
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Muscle-Specific Loss of Apoptosis-Inducing Factor Leads to Mitochondrial Dysfunction, Skeletal Muscle Atrophy, and Dilated Cardiomyopathy

  2005cited by this paper
• Apoptosis-Inducing Factor Triggered by Poly(ADP-Ribose) Polymerase and Bid Mediates Neuronal Cell Death after Oxygen-Glucose Deprivation and Focal Cerebral Ischemia

  2005cited by this paper
• NAD+ as a metabolic link between DNA damage and cell death

  2005cited by this paper
• Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke.

  2004cited by this paper
• Deadly Conversations: Nuclear-Mitochondrial Cross-Talk

  2004influential reference
• The expression of PARP, NF-κB and parvalbumin is increased in Parkinson disease

  2004cited by this paper
• The expression of PARP, NF-kappa B and parvalbumin is increased in Parkinson disease.

  2004influential reference
• A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), Attenuates Neuronal Damage in in Vitro and in Vivo Models of Cerebral Ischemia

  2004influential reference
• The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals

  2004influential reference
• AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis

  2004cited by this paper
• Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling.

  2004influential reference
• Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments.

  2004cited by this paper
• Widespread increased expression of the DNA repair enzyme PARP in brain in ALS

  2004cited by this paper

• Role of mitochondria in neuronal function and survival in the enteric and central nervous systems

  2026cites this paper
• PARP1 Suppression Drives ROS Resistance in Aneuploid Cancer Cells

  2026cites this paper
• Molecular Actions of Sepantronium bromide (YM155) on Survivin-Dependent Cell Death in Cancer and Beyond.

  2026cites this paper
• Encephalitic Alphavirus Infection Induces PARP-1 Hyperactivation Mediated Energy Collapse in Motor Neurons

  2026cites this paper
• Homoisoflavanone Delays Colorectal Cancer Progression via DNA Damage-Induced Mitochondrial Apoptosis and Parthanatos-Like Cell Death.

  2026cites this paper
• Epigenetic consequences of DNA damage.

  2026cites this paper
• Autoimmune neuroinflammation leads to neuronal death via MIF nuclease-mediated parthanatos.

  2026cites this paper
• Ionizing radiation: molecular mechanisms, biological effects, and therapeutic targets

  2026cites this paper
• Targeting DNA Damage and Repair Pathways in Cerebral Ischemic Stroke: From Bench to Bedside

  2026cites this paper
• Empty spiracles homeobox 2 (EMX2) transcription factor functions as a tumor suppressor in renal cell carcinoma by targeting CADM1.

  2025cites this paper
• SARM1 is an essential component of neuronal Parthanatos

  2025cites this paper
• Deferiprone protects against photoreceptor degeneration by inhibiting parthanatos

  2025influential citation
• Advances in non-apoptotic regulated cell death: implications for malignant tumor treatment

  2025cites this paper
• Integrated analysis of multiple programmed cell death-related prognostic genes and functional validation of apoptosis-related genes in osteosarcoma.

  2025cites this paper
• Adenosine diphosphate-ribosylation greatly affects proteins function: a focus on neurodegenerative diseases

  2025cites this paper
• N‐Acety‐L‐Cysteine Alleviates Isoflurane‐Triggered Neuronal Cell Parthanatos by Suppressing Reactive Oxygen Species Accumulation Through the Induction of c‐Jun N‐Terminal Kinase Signaling Pathway Inhibition

  2025cites this paper
• Leveraging diverse cell death patterns in osteosarcoma patients and identification of the function of FADS2 in osteosarcoma cells

  2025cites this paper
• Establishment of an anaplastic stratification signature for gastric cancer based on diverse regulated cell-death

  2025cites this paper
• Parthanatos drives cognitive decline in repeated brain trauma: MSC-derived exosomes as a novel therapeutic strategy

  2025cites this paper
• Integrated multi-optosis model for pan-cancer candidate biomarker and therapy target discovery

  2025cites this paper
• Comprehensive analysis of regulated cell death pathways: intrinsic disorder, protein–protein interactions, and cross-pathway communication

  2025cites this paper
• Comprehensive landscape of cell death mechanisms: from molecular cross-talk to therapeutic innovation in oncology

  2025cites this paper
• Sex-specific cell death mechanisms in rodent sub-acute and chronic stroke.

  2025cites this paper
• Recent advances in antitumor Pt(IV) complexes: Dual targeting and chemoimmunotherapy

  2025cites this paper
• Genetic Mapping and Phenotypic Characterization of the Drosophila AIF e04281 Allele Reveals Mutant Clone Loss in Mosaic Eyes

  2025cites this paper
• Anticancer sensitivities and biological characteristics of HCT116 cells resistant to the selective poly(ADP-ribose) glycohydrolase inhibitor.

  2025cites this paper
• Targeting PAAN/MIF nuclease activity in parthanatos-associated brain diseases.

  2025cites this paper
• The Chemopreventive Effect of Ginsenoside Compound K Is Regulated by PARP-1 Hyperactivation, Which Is Promoted by p62-Dependent SIRT6 Degradation

  2025cites this paper
• The clinically applied PARP inhibitor talazoparib ameliorates imiquimod-induced psoriasis in mice without reducing skin inflammation

  2025cites this paper
• Role of oxeiptosis in disease mechanisms and therapeutic opportunities

  2025cites this paper
• "Yin-Yang" of PARP1 in genotoxic and inflammatory response.

  2025cites this paper
• NADH-bound AIF activates the mitochondrial CHCHD4/MIA40 chaperone by a substrate-mimicry mechanism

  2025cites this paper
• A Comprehensive Review of the Pathophysiology of Neonatal Stroke and a Critique of Current and Future Therapeutic Strategies

  2025cites this paper
• Phenotypic Diversity in Stress-induced Childhood-Onset Neurodegeneration with Variable Ataxia and Seizures: Novel Associations with Parkinsonism, Icthyosis and Cataract

  2025cites this paper
• Cuproptosis-related gene CEP55 as a biomarker of pancreatic adenocarcinoma via multi-omics techniques and experimental validation

  2025cites this paper
• Knowing cell death mechanisms and their applications in the management of disease.

  2025cites this paper
• Emerging Molecular PET Imaging for Cell Death in Neurodegenerative Diseases

  2025cites this paper
• Mitochondria as Regulators of Nonapoptotic Cell Death in Cancer

  2025cites this paper
• Reactive Oxygen Species Across Death Pathways: Gatekeepers of Apoptosis, Ferroptosis, Pyroptosis, Paraptosis, and Beyond

  2025cites this paper
• Mitochondrial activity tunes nociceptor resilience to excitotoxicity.

  2025cites this paper
• Cephalothin, a First-Generation Cephem Antibiotic, Works as a Potent Inducer of Parthanatos.

  2025cites this paper
• Parthanatos: A redox-dependent cell death pathway in cardiovascular disease and myocardial aging.

  2025cites this paper
• Regulated cell death in organ transplantation: recent developments and mechanistic overview

  2025influential citation
• Poly(ADP-ribose) Polymerase 1 Deficiency Attenuates Amyloid Pathology, Neurodegeneration, and Cognitive Decline in a Familial Alzheimer’s Disease Model

  2025cites this paper
• Crosstalk between mitochondrial quality control and novel programmed cell death in pulmonary diseases.

  2025cites this paper
• Mechanism of Endothelial Cell Death in Cerebral Ischemic Stroke and Application of Protective Drugs.

  2025cites this paper
• Update on Nicotinamide and Its Application in the Management of Glaucoma

  2025cites this paper
• Parthanatos and apoptosis: unraveling their roles in cancer cell death and therapy resistance

  2025cites this paper
• CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential

  2025cites this paper
• Deacetylation of nuclear AIF provides a braking mechanism for caspase-independent chromatinolysis and necrotic brain injury

  2025influential citation
• Intracellular metal ion-based chemistry for programmed cell death.

  2025cites this paper
• Identification of Programmed Cell Death-related Biomarkers for the Potential Diagnosis and Treatment of Osteoporosis

  2025cites this paper
• Melittin inhibits MPP+-induced HT22 cell death by suppressing Bax activation and improving mitochondrial function

  2025cites this paper
• Breaching the diatom frustule: Alteromonas macleodii triggers protoplast emergence and programmed necrotic-like cell death in the oceanic diatom Thalassiosira rotula

  2025cites this paper
• Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer

  2025cites this paper
• Selective targeting of genome amplifications and repeat elements by CRISPR-Cas9 nickases to promote cancer cell death

  2025cites this paper
• Necroptosis, Autophagy and Parthanatos in the Pathogenesis of Brain Diseases

  2025cites this paper
• Specific signaling pathways mediated programmed cell death in tumor microenvironment and target therapies

  2025cites this paper
• Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death

  2025cites this paper
• Mechanism of action of Danlou tablets affecting MAFLD via KEAP1-mediated oxeiptosis.

  2025cites this paper
• Apoptosis-inducing factor (AIF) at the crossroad of cell survival and cell death: implications for cancer and mitochondrial diseases

  2025cites this paper
• Epigallocatechin gallate mitigates the motor deficits in a rotenone-induced Parkinson’s disease rat model via promoting protein kinase D1 and inhibiting neuronal Parthanatos

  2025cites this paper
• Surgical Stress and Liver Response: Injury, Regeneration, and Protection.

  2025cites this paper
• AIF‐1 Modulates Endometrial Stromal Cell Proliferation, Invasion, and Migration via Mitochondrial Function

  2025cites this paper
• Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications

  2024cites this paper
• Synergistic Dual Targeting of Thioredoxin and Glutathione Systems Irrespective of p53 in Glioblastoma Stem Cells

  2024cites this paper
• Integrating multi-omics and machine learning survival frameworks to build a prognostic model based on immune function and cell death patterns in a lung adenocarcinoma cohort

  2024cites this paper
• Integrative analysis of multiple cell death model for precise prognosis and drug response prediction in gastric cancer

  2024cites this paper
• Protein modification in neurodegenerative diseases

  2024cites this paper
• CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos

  2024cites this paper
• Navigating the complexities of cell death: Insights into accidental and programmed cell death.

  2024cites this paper
• Molecular mechanisms of cell death by parthanatos: More questions than answers

  2024cites this paper
• Programmed cell death, from liver Ischemia–Reperfusion injury perspective: An overview

  2024cites this paper
• Identification and clinical validation of diverse cell-death patterns-associated prognostic features among low-grade gliomas

  2024cites this paper
• Disulfidptosis: A new type of cell death

  2024cites this paper
• Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches

  2024cites this paper
• Understudied targets of the ischemia-reperfusion injury pathogenesis in liver transplantation

  2024cites this paper
• Approaches to selective and potent inhibition of glioblastoma by vanadyl complexes: Inducing mitotic catastrophe and methuosis.

  2024cites this paper
• Parthanatos: Mechanisms, Modulation, and therapeutic prospects in neurodegenerative disease and stroke.

  2024cites this paper
• 4'-O-methylbavachalcone alleviates ischemic stroke injury by inhibiting parthanatos and promoting SIRT3.

  2024cites this paper
• An Integrated Machine Learning Framework Identifies Prognostic Gene Pair Biomarkers Associated with Programmed Cell Death Modalities in Clear Cell Renal Cell Carcinoma.

  2024cites this paper
• Biomarker screening using integrated bioinformatics for the development of “normal—impaired glucose intolerance—type 2 diabetes mellitus”

  2024cites this paper
• Blocking the Self‐Destruct Program of Dopamine Neurons through Macrophage Migration Inhibitory Factor Nuclease Inhibition

  2024cites this paper
• Involvement of regulated cell deaths in aging and age-related pathologies.

  2024cites this paper
• Transcriptomic features of programmed and inflammatory cell death in gingival tissues.

  2024cites this paper
• Experimental evidence for Parthanatos-like mode of cell death of heat-damaged human skin fibroblasts in a cell culture-based in vitro burn model.

  2024cites this paper
• Cell Death in Pulmonary Arterial Hypertension

  2024cites this paper
• Pimpinellin ameliorates macrophage inflammation by promoting RNF146‐mediated PARP1 ubiquitination

  2024cites this paper
• Piceid Octanoate Protects Retinal Cells against Oxidative Damage by Regulating the Sirtuin 1/Poly-ADP-Ribose Polymerase 1 Axis In Vitro and in rd10 Mice

  2024cites this paper
• Cell death induced by acute kidney injury: A perspective on the contributions of accidental and programmed cell death.

  2024cites this paper
• Molecular prognostic of nine parthanatos death‐related genes in glioma, particularly in COL8A1 identification

  2024cites this paper
• The importance of murine phospho-MLKL-S345 in situ detection for necroptosis assessment in vivo

  2024cites this paper
• Apoptosis and NETotic cell death affect diabetic nephropathy independently: An study integrative study encompassing bioinformatics, machine learning, and experimental validation.

  2024cites this paper
• Parthanatosis in virus-associated liver and colon cancer

  2024cites this paper
• Programmed cell death-index (PCDi) as a prognostic biomarker and predictor of drug sensitivity in cervical cancer: a machine learning-based analysis of mRNA signatures

  2024cites this paper
• Regional- and cell type-specific changes of the human brain during aging

  2024cites this paper
• Poly ADP-ribose signaling is dysregulated in Huntington disease

  2024cites this paper
• Aggregability of the SQSTM1/p62-based aggresome-like induced structures determines the sensitivity to parthanatos

  2024cites this paper
• Excavating regulated cell death signatures to predict prognosis, tumor microenvironment and therapeutic response in HR+/HER2- breast cancer

  2024cites this paper
• Two palladium (II) complexes derived from halogen-substituted Schiff bases and 2-picolylamine induce parthanatos-type cell death in sensitive and multi-drug resistant CCRF-CEM leukemia cells.

  2023cites this paper